News

New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Deliver 30% Savings, Halve Timelines and Cut Risk for Biotechs

4 June 2024

New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Deliver 30% Savings, Halve Timelines and Cut Risk for Biotechs

Avance Clinical is sharing new data at BIO 2024 from Frost & Sullivan research showing biotechs save more than 30% in costs and halve start-up times with CROs that have in-house scientific and regulatory affairs.

  • Reset
Join Avance Clinical In Seoul At KoNECT Korea 2023

14 September 2023

Join Avance Clinical In Seoul At KoNECT Korea 2023

Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will visit Seoul in October to expand on collaborative opportunities with South Korean biotech companies.

Avance Clinical Earns Frost & Sullivan’s 2023 Best Practices Customer Value Leadership Award for Delivering High-quality Clinical Trials Based on Globally Accepted Data

7 August 2023

Avance Clinical Earns Frost & Sullivan’s 2023 Best Practices Customer Value Leadership Award for Delivering High-quality Clinical Trials Based on Globally Accepted Data

Frost & Sullivan recently researched the Asia-Pacific biotechnology contract research organization industry and, based on its findings, recognizes Avance Clinical with the 2023 Customer Value Leadership Award.

Avance Clinical Customer Leadership Award Frost & Sullivan Analyst Report

7 August 2023

Avance Clinical Customer Leadership Award Frost & Sullivan Analyst Report

Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will visit Seoul in October to expand on collaborative opportunities with South Korean biotech companies.

Endpoints News Feature: GlobalReady Saving Trial Cost and Time

1 August 2023

Endpoints News Feature: GlobalReady Saving Trial Cost and Time

Frost & Sullivan recently researched the Asia-Pacific biotechnology contract research organization industry and, based on its findings, recognizes Avance Clinical with the 2023 Customer Value Leadership Award.

Avance Clinical Opens New North American Headquarters

29 June 2023

Avance Clinical Opens New North American Headquarters

Avance Clinical expanded operations in the US last year to offer its clients a seamless drug development journey from Australia to the US with the same CRO.

Avance Clinical at ASCO & BIO 2023: Early Phase Oncology Trials Increasingly Elaborate and Demand More Patients

30 May 2023

Avance Clinical at ASCO & BIO 2023: Early Phase Oncology Trials Increasingly Elaborate and Demand More Patients

Avance Clinical the leading award-winning Australian and North American CRO that offers ClinicReady and GlobalReady for early-phase biotech companies to speed up the path to regulatory approval, says early-phase oncology studies are increasingly more complex and demand more patients.

Avance Clinical Joins Global Health Summit Campaign for Faster Access to Life-Changing and Life-Saving Therapies

25 May 2023

Avance Clinical Joins Global Health Summit Campaign for Faster Access to Life-Changing and Life-Saving Therapies

Avance Clinical has been invited to join the Global Health Summit campaign which will be featured on Reuters.

Avance Clinical CEO Joins Global BioPharma Panel for Evolution Europe Summit 2023

18 April 2023

Avance Clinical CEO Joins Global BioPharma Panel for Evolution Europe Summit 2023

Avance Clinical the leading award-winning Australian and North American biotech CRO that offers a GlobalReady program to early-phase biotech companies to speed up the path to regulatory approval, has been invited to join the Evolution Europe Summit 2023

Avance Clinical Leads DCT Technology Adoption Globally

10 April 2023

Avance Clinical Leads DCT Technology Adoption Globally

GlobalData and Clinical Trial Arena have identified Avance Clinical as the global leader in Decentralized Clinical Trial (DCT) technology adoption with 46% of their trials incorporating some elements of DCT technologies in 2022 including telemedicine, remote monitoring, and digital data collection.

Enveric Biosciences Selects Australian CRO, Avance Clinical, in Preparation for Phase 1 Study of EB-373

27 March 2023

Enveric Biosciences Selects Australian CRO, Avance Clinical, in Preparation for Phase 1 Study of EB-373

EB-373, a proprietary psilocin prodrug, is on track to start its first-in-human clinical trial in the fourth quarter of 2023

Avance Clinical Appoints North America SVP with Global Contract Research Organization, Data Quality and DCT Expertise

1 March 2023

Avance Clinical Appoints North America SVP with Global Contract Research Organization, Data Quality and DCT Expertise

Avance Clinical today announced the appointment of John Mann as Senior Vice President, North America Operations.

Avance Clinical Expands Biometrics Team into India to Support Biotech Trials Demand in US and Australia

13 February 2023

Avance Clinical Expands Biometrics Team into India to Support Biotech Trials Demand in US and Australia

Award-winning CRO Avance Clinical, which currently has the largest Biometrics team in Australia, is expanding further with global hires and a specialist hub in Bangalore, India to support growing demand.

Proven industry
experience & expertise

500+

Studies in the past 5 years

330+

Experienced team members

18k+

Participants past 5 years

30

Years of CRO experience